March 19, 2009 - Sanofi-aventis said yesterday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-3 in favor of the approval of Multaq (dronedarone) to treat patients with non-permanent atrial fibrillation (AF).
March 19, 2009 – Led by Senator Richard Durbin (D-IL) and Congressman Zack Space (D-OH), the federal government yesterday introduced new legislation that will address the needs of those affected by congenital heart defects (CHDs).
March 19, 2009 - The LUMEN 2009: The Symposium on Optimal Treatments for Acute MI recently hosted hundreds of paramedics, emergency department staff, nurses, internists, hospitalists, interventional cardiologists, cardiac and vascular surgeons, and hospital administrators, to discuss the state of America’s healthcare system and the fight to save vulnerable heart attack patients.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 19, 2009 - The FDA has approved an investigational device exemption (IDE) for a multicenter clinical trial of IDEV Technologies Inc.’s SUPERA stent, a novel stent platform designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA).
March 19, 2009 - Digisonics will showcase their new DigiView Cath package with its imaging and reporting capabilites for the first time at the ACC 2009 meeting in Orlando, FL at booth #1773.
March 18, 2009 - Flexible Stenting Solutions Inc. (FSS) this week submitted an investigational device exemption (IDE) application to the FDA for its FlexStent Femoropopliteal SE Stent System for the treatment of peripheral artery disease in the superficial femoral and popliteal arteries.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 18, 2009 - Cardiologists Edward Tadajweski, M.D., and Jeffrey L. Williams, M.D., MS, FACC, are the first in the U.S. to perform 3D imaging of complex cardiac anatomy using GE's Innova 3D imaging system.
March 18, 2009 - The U.S. Preventive Services Task Force (USPSTF) found that regular aspirin use reduces first heart attacks in men and first strokes in women and recommends daily aspirin use for certain patient populations.
March 18, 2009 - The success of Massachusetts hospitals and physicians to incorporate information technology (IT) into healthcare demonstrates the importance of incentives, according to two studies conducted by CSC and sponsored by Blue Cross Blue Shield of Massachusetts.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 18, 2009 - GE said yesterday it was awarded two 10-year contracts by the Defense Supply Center Philadelphia (DSCP) to provide products for comprehensive patient monitoring solutions, including acute patient monitoring, networking, telemetry systems, vital signs monitoring. Combined, these two contracts are valued at a maximum of $63 million annually.
March 18, 2009 – The American Heart Association (AHA) is urging Congress to accelerate its efforts to enact comprehensive healthcare reform and increase research funding to prevent setbacks in the fight against heart disease and stroke.
March 18, 2009 - Vicor Technologies Inc. has entered into a collaborative research agreement with the University of Rochester and the Catalan Institute of Cardiovascular Sciences in Barcelona to study sudden cardiac death.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 17, 2009 – Twelve-month data from the ATLANTA Trial shows that the CATANIA Coronary Stent System with NanoThin Polyzene-F offers sustained benefit in the treatment of de novo coronary lesions and maximizes endothelialization, while reducing restenosis, thrombogenicity, and the need for long-term dual-antiplatelet therapy.
March 17, 2009 - Edwards Lifesciences Corp. announced it has completed enrollment in the 350-patient nonsurgical study arm of its PARTNER Trial for the Edwards SAPIEN transcatheter aortic heart valve.
March 17, 2009 - eCardio Diagnostics has launched an Academic Medicine initiative to provide a tailored offering to university-based health systems, marking the first time an arrhythmia monitoring company has addressed the unique workflow, teaching and research responsibilities of academic medical centers. The eCardio Academic Medicine service offers: